Combined anticancer effects of sphingosine kinase inhibitors and sorafenib. [electronic resource]
Producer: 20120123Description: 1132-42 p. digitalISSN:- 1573-0646
- Adamantane -- administration & dosage
- Adenocarcinoma -- drug therapy
- Administration, Oral
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Benzenesulfonates -- administration & dosage
- Caspase 3 -- metabolism
- Caspase 7 -- metabolism
- Catechols -- administration & dosage
- Cell Line, Tumor
- DNA Fragmentation -- drug effects
- Drug Synergism
- Female
- Humans
- Kidney Neoplasms -- drug therapy
- Mice
- Mice, SCID
- Niacinamide -- analogs & derivatives
- Pancreatic Neoplasms -- drug therapy
- Phenylurea Compounds
- Phosphotransferases (Alcohol Group Acceptor) -- antagonists & inhibitors
- Pyridines -- administration & dosage
- Sorafenib
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.